Literature DB >> 2006014

Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features.

R W Baloh1, A Winder.   

Abstract

Five patients who presented with long-standing episodic vertigo had ocular motor signs localizing to the vestibulocerebellum. In each patient, the episodic vertigo was either abolished or markedly decreased in frequency and severity with acetazolamide therapy. In 4, other family members had identical symptoms and signs. This syndrome is 1 of the few treatable causes of chronic episodic vertigo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006014     DOI: 10.1212/wnl.41.3.429

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Medical treatment of nystagmus and its visual consequences.

Authors:  John S Stahl; Gordon T Plant; R John Leigh
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

2.  Acquired Nystagmus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 3.  An Overview of the Current State and the Future of Ataxia Treatments.

Authors:  Kimberly Tsu Kwei; Sheng-Han Kuo
Journal:  Neurol Clin       Date:  2020-02-27       Impact factor: 3.806

4.  A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p.

Authors:  P L Kramer; Q Yue; S T Gancher; J G Nutt; R Baloh; E Smith; D Browne; K Bussey; E Lovrien; S Nelson
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

Review 5.  The spinocerebellar ataxias: order emerges from chaos.

Authors:  Russell L Margolis
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

6.  Novel splice site CACNA1A mutation causing episodic ataxia type 2.

Authors:  M A Kaunisto; H Harno; M Kallela; H Somer; R Sallinen; E Hämäläinen; P J Miettinen; J Vesa; A Orpana; A Palotie; M Färkkilä; M Wessman
Journal:  Neurogenetics       Date:  2003-10-07       Impact factor: 2.660

Review 7.  Pharmacological treatment of vertigo.

Authors:  Timothy C Hain; Mohammed Uddin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.